Increased expression of MyD88 and association with paclitaxel resistance in breast cancer (Q27853281)

1

0 references

Zhenhua Ni

2

0 references

Yueping Zhan

3

0 references

Qianqian Kong

4

0 references

Jian Xu

5

0 references

Jiemin Jiang

6

0 references

Rong Wu

7

0 references

Xiangdong Kang

8

0 references

publication date

May 2016

0 references

published in

Tumor Biology

0 references

volume

37

0 references

issue

5

0 references

page(s)

6017-25

0 references

cites work

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4436-5

CYP2C8*3 predicts benefit/risk profile in breast cancer patients receiving neoadjuvant paclitaxel

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4436-5

The taccalonolides and paclitaxel cause distinct effects on microtubule dynamics and aster formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4436-5

Prediction of paclitaxel resistance in breast cancer: is CYP1B1*3 a new factor of influence?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4436-5

Dual function of MyD88 in RAS signaling and inflammation, leading to mouse and human cell transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4436-5

TLR-4 signaling promotes tumor growth and paclitaxel chemoresistance in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4436-5

TLR4 signaling induced by lipopolysaccharide or paclitaxel regulates tumor survival and chemoresistance in ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4436-5

High expression of Toll-like receptor 4/myeloid differentiation factor 88 signals correlates with poor prognosis in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4436-5

miR-135a contributes to paclitaxel resistance in tumor cells both in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4436-5

Autocrine production of interleukin-6 confers cisplatin and paclitaxel resistance in ovarian cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4436-5

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4436-5

NF-kappaB activation by tumour necrosis factor requires the Akt serine-threonine kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4436-5

Activation of phosphatidylinositol 3-kinase in response to interleukin-1 leads to phosphorylation and activation of the NF-kappaB p65/RelA subunit

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4436-5

Lipopolysaccharide activates Akt in human alveolar macrophages resulting in nuclear accumulation and transcriptional activity of beta-catenin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4436-5

Triggering of Toll-like receptor 4 expressed on human head and neck squamous cell carcinoma promotes tumor development and protects the tumor from immune attack.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4436-5

Myeloid differentiation factor 88 promotes growth and metastasis of human hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4436-5

Phosphoinositide 3-kinase signaling is critical for ErbB3-driven breast cancer cell motility and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4436-5

YXXM motifs in the PDGF-beta receptor serve dual roles as phosphoinositide 3-kinase binding motifs and tyrosine-based endocytic sorting signals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4436-5

Roles of mitogen-activated protein kinase and phosphoinositide 3'-kinase in ErbB2/ErbB3 coreceptor-mediated heregulin signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4436-5

Interleukin-6, multidrug resistance protein-1 expression and response to paclitaxel in women with metastatic breast cancer: results of cancer and leukemia group B trial 159806

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4436-5

MyD88 predicts chemoresistance to paclitaxel in epithelial ovarian cancer.

21 January 2018

1 reference

12 December 2020

MyD88 expression is associated with paclitaxel resistance in lung cancer A549 cells

1 reference

12 December 2020

Enriched variations in TEKT4 and breast cancer resistance to paclitaxel

1 reference

12 December 2020

The microtubule-affecting drug paclitaxel has antiangiogenic activity

1 reference

12 December 2020